Trial Profile
Pegylated interferon alfa-2a USE FOR CONTROLLING virological rebound after suspension of antiretroviral treatment IN PATIENTS WITH CHRONIC HIV INFECTION
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms IFNHIV
- 24 Jul 2014 New trial record